David Bredt Rapport Therapeutics, Inc. (RAPP) insider trading activity

Shares Held (Direct Ownership) 396K

3.43% 3M change

n/a 12M change

Total Value Held N/A

David Bredt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 15 2026	SELL Open market or private sale	$230,520 $27.12 p/Share	8,500 Reduced 2.1%	395,575 Common Stock
Dec 31 2025	SELL Grant, award, or other acquisition	-	18,000 Reduced 4.2%	410,642 Common Stock
Dec 31 2025	SELL Open market or private sale	$197,338 $30.05 p/Share	6,567 Reduced 1.6%	404,075 Common Stock
Dec 15 2025	SELL Open market or private sale	$257,720 $30.32 p/Share	8,500 Reduced 2.12%	392,642 Common Stock
Nov 17 2025	SELL Open market or private sale	$213,520 $25.12 p/Share	8,500 Reduced 2.07%	401,142 Common Stock
Oct 15 2025	SELL Open market or private sale	$220,575 $25.95 p/Share	8,500 Reduced 2.03%	409,642 Common Stock
Sep 15 2025	SELL Open market or private sale	$206,295 $24.27 p/Share	8,500 Reduced 1.99%	418,142 Common Stock

Aug 15 2025	SELL Open market or private sale	$130,815 $15.39 p/Share	8,500 Reduced 1.95%	426,642 Common Stock
Jul 15 2025	SELL Open market or private sale	$119,000 $14.0 p/Share	8,500 Reduced 1.92%	435,142 Common Stock
Jun 16 2025	SELL Open market or private sale	$93,500 $11.0 p/Share	8,500 Reduced 1.88%	443,642 Common Stock
May 15 2025	SELL Open market or private sale	$81,260 $9.56 p/Share	8,500 Reduced 1.85%	452,142 Common Stock
Apr 15 2025	SELL Open market or private sale	$81,345 $9.57 p/Share	8,500 Reduced 1.81%	460,642 Common Stock
Mar 14 2025	SELL Open market or private sale	$92,225 $10.85 p/Share	8,500 Reduced 1.78%	469,142 Common Stock

Chief Scientific Officer

Boston, MA

Receive a notification when an Institution or Guru buys or sells RAPP shares.

Notify only if

Value

Get notified when an Rapport Therapeutics, Inc. insider buys or sells RAPP shares.

Notify only if

Operation

Value

Type

Receive news related to Rapport Therapeutics, Inc.